Atai Life Sciences N.V.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Atai Life Sciences N.V. generated cash of -$84,118,000, which is more than the previous year. Cash used in financing activities reached the amount of -$8,355,000 last year. Net change in cash is therefore -$145,579,000.
Cash Flow
| 2019 | -7.84M | -9.03M | 40.38M |
|---|---|---|---|
| 2020 | -20.76M | -28.27M | 113.05M |
| 2021 | -63.24M | -81.27M | 409.86M |
| 2022 | -104.46M | -86.84M | 20.78M |
| 2023 | -84.11M | -53.29M | -8.35M |
ATAI Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 190.61M | 362.26M | 97.24M | 30.06M | 6.92M |
Operating activities | |||||
Net income | -40.22M | -157.41M | -174.24M | -178.62M | -24.38M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 319K | 168K | 47K | 24K | 6K |
Stock-based compensation expense | 32.98M | 42.37M | 63.36M | 67.15M | 57K |
| Deferred income tax benefit | 32.98M | 42.37M | 63.36M | 67.15M | 57K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 2.13M | -3.03M | 2.3M | 1.70M | 249K |
Cash generated by operating activities | -84.11M | -104.46M | -63.24M | -20.76M | -7.84M |
Investing activities | |||||
Purchases Of Investments | -185.26M | -309.65M | -23.65M | -23.92M | -11.55M |
Investments In Property Plant And Equipment | -590K | -1.02M | -1.12M | -59K | -19K |
Acquisitions Net | -443K | 0 | -52.93M | -2.08M | -456K |
Cash generated by investing activities | -53.29M | -86.84M | -81.27M | -28.27M | -9.03M |
Financing activities | |||||
Common Stock Issued | 225K | 4.63M | 409.88M | 82.43M | 42.68M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 15M | -1.58M | -32.50M | 0 |
Cash used in financing activities | -8.35M | 20.78M | 409.86M | 113.05M | 40.38M |
Net Change In Cash | -145.57M | -171.65M | 265.02M | 67.18M | 23.14M |
Cash at end of period | 45.03M | 190.61M | 362.26M | 97.24M | 30.06M |
| Data source | Data source | Data source |